Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo

Blood

Volumn 90, Issue 8, 1997, Pages 3160-3166

  Funakoshi, Satoshi ^b   Hirano, Akio ^b   Beckwith, Margaret ^b   Asai, Osamu ^b   Jorgensen, Gitte ^b   Tian, Zhi Gang ^b   Hornick, Jason L ^b   Hu, Peisheng ^b   Khawli, Leslie A ^b   Epstein, Alan L ^b   Longo, Dan L ^b   Murphy, William J ^a  

^a SAIC FREDERICK INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER GROWTH; CANCER SURVIVAL; CELL DEATH; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030842883     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.3160     Document Type: Article

References (23)

1. Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R: Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: Correlation with clinical responses. Blood 69:199, 1987
2. Brown SL, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElder R, Basham T, Warnke R, Merigan TC, Levy R: Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651, 1989
3. Dyer MJS, Hale G, Hayhoe FGJ, Waldmann H: Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: Influence of antibody isotype. Blood 73:1431, 1989
4. Duran A, Brous N, Rosenberg SF, De Saint Basile G, Fischer M, Fischer A: Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest 90:945, 1992
5. Beckwith M, Fenton RG, Katona IM, Longo DL: Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line. Blood 87:202, 1996
6. Kohler HR, Dhei J, Alberti G, Krammer PH: Ultrastructural analysis of apoptosis induced by the monoclonal antibody anti-APO-1 on a lymphoblastoid B cell line. Ultrastruct Pathol 14:513, 1990
7. Ashwell JD, Longo DL, Bridges SH: T-cell elimination as a result of T-cell receptor-mediated activation. Science 237:61, 1987
8. Page DM, Defranco A: Role of phosphoinositide-derived second messengers in mediated anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells. J Immunol 140:3717, 1988
9. Ghetie MA, Picker LJ, Richardson JA, Tucker K, Uhr JW, Vitetta ES: Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest. Blood 83:1329, 1994
10. Beckwith M, Longo DL, O'Connel ICD, Moratz CM, Urba WJ: Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines. J Natl Cancer Inst 82:501, 1990
11. Bridges SH, Kruisbeek AM, Longo DL: Selective in vivo antitumor effect of monoclonal anti-I-A antibody on B cell lymphoma. J Immunol 139:4242, 1987
12. Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, Armitage RJ, Fanslow WC, Spriggs MK, Murphy WJ: Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 83:2787, 1994
13. Epstein AL, Marder RJ, Winter JN, Stathopoulos E, Chen F, Parker JW, Taylor CR: Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immnodiagnostic and immunotherapeutic potential. Cancer Res 47:830, 1987
14. Hu P, Glasky MS, Yun A, Alauddin MM, Hornick JL, Khawli LA, Epstein AL: A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system. Hum Antibod Hybrid 6:57, 1995
15. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256, 1988
16. Nakamine H, Masih AS, Okano M, Taguchi Y, Pirruccelo SJ, Davis JR, Mahloch ML, Beisel KW, Kleveland K, Sanger WG, Purtilo DT: Characterization of clonality of Epstein-Barr virus-in-duced human B lymphoproliferative disease in mice with severe combined immunodeficiency. Am J Pathol 142:139, 1993
17. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG: Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell line. Blood 83:2045, 1994
18. Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL: Human-mouse lymphoid chimeras: Host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 22:1421, 1992
19. Beckwith M, Urba WJ, Ferris DK, Frete CE, Kuhns DB, Moratz CM, Longo DL: Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation. J Immunol 147:2411, 1991
20. Hu E, Epstein AL, Naeve GS, Gill I, Martin S, Sherrod A, Nichols P, Chen D, Mazumder A, Levine AM: A phase Ia clinical trial of Lym-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies. Hematol Oncol 7:155, 1989
21. DeNardo GL, Lewis JP, DeNardo SJ, O'Grady LF: Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia. Cancer 73:1425, 1994
22. DeNardo GL, DeNardo SJ, Meares CF, Kukis DL, Diril H, McCall MJ, Adams GP, Mausner LF, Moody DC, Desphande SV: Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and patients with lymphoma. Antib Immunoconjug Radiopharm 4:777, 1991
23. Gottschalk AR, Quint/Eans J: Apoptosis in B lymphocytes: The WEHI-231 perspective. Immunol Cell Biol 73:8, 1995